Transine Therapeutics Limited

General information

Name:

Transine Therapeutics Ltd

Office Address:

30 Broad Street Great Cambourne CB23 6HJ Cambridge

Number: 11532498

Incorporation date: 2018-08-22

End of financial year: 31 December

Category: Private Limited Company

Status: Active

Description

Data updated on:

This firm is based in Cambridge with reg. no. 11532498. This firm was established in the year 2018. The office of the firm is situated at 30 Broad Street Great Cambourne. The area code for this location is CB23 6HJ. This company's classified under the NACE and SIC code 72110 which means Research and experimental development on biotechnology. Transine Therapeutics Ltd reported its account information for the financial period up to 2022/12/31. The latest annual confirmation statement was released on 2023/08/21.

As stated, this specific limited company was incorporated 6 years ago and has so far been managed by nine directors, and out of them five (Miles G., Jan T., Christian J. and 2 other directors have been described below) are still functioning. In addition, the managing director's responsibilities are constantly assisted with by a secretary - Sean B., who was chosen by the following limited company in January 2024.

Company staff

Sean B.

Role: Secretary

Appointed: 01 January 2024

Latest update: 8 March 2024

Miles G.

Role: Director

Appointed: 01 November 2021

Latest update: 8 March 2024

Jan T.

Role: Director

Appointed: 05 July 2021

Latest update: 8 March 2024

Christian J.

Role: Director

Appointed: 04 August 2020

Latest update: 8 March 2024

Alan B.

Role: Director

Appointed: 10 December 2019

Latest update: 8 March 2024

Michael J.

Role: Director

Appointed: 03 September 2018

Latest update: 8 March 2024

People with significant control

The companies that control this firm include: Takeda Pharmaceutical Company Limited owns 1/2 or less of company shares and has 1/2 or less of voting rights. This business can be reached in Osaka at Doshomachi 4 Chrome, Chuo-Ku, 540-8645 and was registered as a PSC under the registration number 1200-01-077461.

Takeda Pharmaceutical Company Limited
Address: 1-1 Doshomachi 4 Chrome, Chuo-Ku, Osaka, 540-8645, Japan
Legal authority Japan
Legal form Public Limited Company
Country registered Japan
Place registered Osaka Legal Affairs Bureau
Registration number 1200-01-077461
Notified on 28 January 2020
Nature of control:
1/2 or less of voting rights
1/2 or less of shares
Piero C.
Notified on 22 August 2018
Ceased on 4 August 2020
Nature of control:
1/2 or less of voting rights
right to manage directors
1/2 or less of shares
Stefano G.
Notified on 22 August 2018
Ceased on 4 August 2020
Nature of control:
1/2 or less of voting rights
right to manage directors
1/2 or less of shares

Accounts Documents

Account next due date 30 September 2024
Account last made up date 31 December 2022
Confirmation statement next due date 04 September 2024
Confirmation statement last made up date 21 August 2023

Company filings

Filing category

Hide filing type
Accounts Address Capital Change of name Confirmation statement Incorporation Officers Persons with significant control Resolution
Free Download
New director was appointed on 2024-04-08 (AP01)
filed on: 18th, April 2024
officers
Free Download Download filing (2 pages)

Search other companies

Services (by SIC Code)

  • 72110 : Research and experimental development on biotechnology
5
Company Age

Closest Companies - by postcode